Page last updated: 2024-10-21

2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Brain Neoplasms

2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine has been researched along with Brain Neoplasms in 1 studies

2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine: a selective inhibitor of nitric oxide synthase; structure given in first source

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oyoshi, T1
Nomoto, M1
Hirano, H1
Kuratsu, J1

Other Studies

1 other study available for 2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Brain Neoplasms

ArticleYear
Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry.
    Journal of pharmacological sciences, 2003, Volume: 91, Issue:1

    Topics: Animals; Brain Neoplasms; Enzyme Inhibitors; Glioma; Half-Life; Immunohistochemistry; Male; Microdia

2003